Galectin Therapeutics completes warrant exercise

Galectin Therapeutics Inc. (NASDAQ:GALT), Norcross, Ga. Business: Cancer, Drug delivery, Hepatic Date completed: 8/28/13 Type: Warrant exercise Raised: $3 million Shares: 710,834 Price: $4.20 Shares a...